We previously reported that noradrenergic (NA) neurons in the nucleus of the solitary tract (NST) are necessary for exogenous cholecystokinin octapeptide to inhibit food intake in rats. To determine whether NST NA neurons also are necessary for lithium chloride (LiCl) to inhibit food intake and/or to support conditioned avoidance behavior, saporin toxin conjugated to an antibody against dopamine beta hydroxylase (DSAP) was microinjected bilaterally into the NST to ablate resident NA neurons. DSAP and sham control rats subsequently were tested for the ability of LiCl (0.15M, 2% BW) to inhibit food intake and to support conditioned flavor avoidance (CFA). LiCl-induced hypophagia was significantly blunted in DSAP rats, and those with the most extensive loss of NST NA neurons demonstrated the most attenuated LiClinduced hypophagia. Conversely, LiCl supported a robust CFA that was of similar magnitude in sham control and DSAP rats, including rats with the most extensive NA lesions. A terminal Fos study revealed intact LiCl-induced Fos expression in the laPBN and CeA in DSAP rats, despite significant loss of NST NA neurons and attenuated Fos activation of corticotropinreleasing hormone-positive neurons in the paraventricular nucleus of the hypothalamus (PVN).
Lithium chloride (LiCl) is commonly used in experiments to study central neural pathways and mechanisms involved in "sickness behavior". Systemic administration of LiCl in rats dose-dependently inhibits food intake, activates the hypothalamic-pituitary-adrenal (HPA) stress axis, and promotes conditioned flavor avoidance (CFA) (2, 3, 6, 9, 10, 34, 41, 50, 51, 54) . CFA represents a learned association between a novel flavor and an aversive postingestive event (48) . Because toxic, rancid, and other potentially dangerous foods coexist with most animals, CFA is believed to have evolved in order to protect animals (especially nonemetic species such as rats) from poisoning themselves out of the gene pool (47) . The ability of LiCl to inhibit food intake and to support robust conditioned avoidance of associated flavors is evidence that LiCl has aversive qualities, and that it recruits central neural circuits that underlie both hypophagia and adaptive associative learning.
It is widely held that LiCl-induced hypophagia is a direct consequence of LiCl-induced malaise. However, relatively low doses of LiCl that do not inhibit ad libitum or deprivationinduced food intake can nevertheless support conditioned taste aversion and avoidance behavior in rats (2, 41) , and an experimental dissociation between the ability of LiCl to produce CFA and to inhibit food intake has been reported (6) . In the latter study, LiCl-induced CFA was abolished in rats with aspiration lesions of the chemosensitive area postrema (AP), although LiCl still promoted hypophagia and increased plasma levels of oxytocin (6) . Thus, LiCl inhibits food intake and recruits hypothalamic endocrine responses in AP-lesioned rats that are either incapable of experiencing LiCl-induced malaise, or are incapable of associating malaise with a novel flavor.
First-order CNS regions that are activated to express the immediate-early gene product Fos after LiCl treatment include the AP, which lacks a blood-brain barrier, and the subjacent nucleus of the solitary tract (NST). Activated AP and NST neurons include noradrenergic (NA) neurons that are immunoreactive for dopamine beta hydroxylase (DbH), and non-NA neurons (30, 36) . NA and non-NA neurons in the AP and NST relay LiCl-initiated signals to other brain regions involved in sickness behavior, CFA learning, and stress responses, including the lateral parabrachial nucleus (laPBN), the central nucleus of the amygdala (CeA), and the paraventricular nucleus of the hypothalamus (PVN). Conditioned taste aversion and CFA responses to LiCl in rats require an intact AP and PBN, and amygdala (3, 6, 13, 17, 31, 32, (40) (41) (42) 58) . However, the requisite neural substrates for LiCl-induced hypophagia are less well defined.
A novel immunotoxin comprising an antibody to the NA synthetic enzyme DbH conjugated to saporin toxin (DSAP) destroys NA neurons selectively and site-specifically (1, 11, 12, 25, 35, 39, 56) . A study from our laboratory used DSAP lesions to reveal that NA neurons in the caudal NST are necessary for exogenous cholecystokinin (CCK) to inhibit food intake in rats, likely due to disruption of caudal brainstem circuits that mediate CCK-induced hypophagia (35) . Caudal medullary NA neurons also are necessary for CCK to activate Fos expression in the PVN, but are unnecessary to activate the laPBN and CeA, in which CCKinduced Fos expression appeared to be increased normally in rats with complete bilateral DSAP lesions of the caudal NST (35) . The present study used a similar DSAP lesioning approach to test the hypothesis that the neural substrates of LiCl-induced hypophagia require NA neurons within the caudal dorsomedial medulla, whereas the same NA neurons are unnecessary for the ability of LiCl to recruit AP and laPBN neural circuits that underlie CFA learning.
Materials and Methods
Animals. All procedures conformed to National Institutes of Health guidelines and were approved by the University of Pittsburgh Animal Care and Use Committee. Data from 43 adult male Sprague-Dawley rats (Harlan Laboratories) are included in this report. Singly-housed rats had ad libitum access to water and pelleted rat chow (Purina, St. Louis, MO) except during food intake and CFA experiments, as detailed below. Colony rooms were maintained at 22-23°C and kept on a 12:12 hr light-dark cycle, with lights on from 0700-1900 hr.
Experimental groups and body weights. Rats received bilateral injections of toxin (DSAP; Advanced Targeting Systems, San Diego; n=27) or vehicle (0.15M NaCl; sham control; n=16) into the caudal NST, as described below. Each rat was subsequently used in a CFA experiment, in a food intake experiment, and in a terminal Fos study. Thus, each rat received three LiCl treatments over the course of the study.
Rats weighed 187-212 g at the time of DSAP or sham surgery, 240-276 g at the time of CFA and food intake experiments, and 265-297 g at the time of the terminal Fos study. Body weights did not differ significantly at any experimental time point in DSAP vs. sham control rats. A previous report from our laboratory described a transient anorexia and BW loss that emerged in some rats approximately 1 week after bilateral DSAP injections into the caudal NST (35) . The initial anorexia observed in that study resolved, and all rats gradually recovered normal BW growth curves (35) . With that result in mind, all rats in the present study were offered a palatable liquid diet in addition to their regular chow for 2 days prior to brainstem injection surgery and for 5-7 days after surgery. The lack of lesion-related BW loss in the present study (see Results) could be due to the dietary intervention, and/or to the smaller number of DSAP injection sites (i.e., 4 per rat as described below, vs. 6 per rat in our previous study). A smaller number of DSAP injection sites were used in the present study in an effort to reduce toxin spread to NA neurons within the ventrolateral medulla.
NST microinjection. DSAP or vehicle microinjections were made bilaterally into the NST at four sites in each rat, with two injection sites in the left NST and two in the right. DSAP was freshly prepared from a frozen stock solution within 2 hr of injection. Injection sites encompassed the caudal medial NST region that contains the highest incidence of Fos expression by DbH-positive NA neurons after LiCl treatment, corresponding to the location of the A2 NA cell group (30, 37) . Rats were anesthetized (2-5% halothane in 100% oxygen) and secured in a stereotaxic frame using blunt ear bars, with the nose ventroflexed. The skin over the dorsal neck surface was shaved, sterilized, and incised, and the neck muscles retracted and bluntly dissected to expose the meninges overlying the dorsal surface of the caudal medulla. With the aid of a surgical microscope, the meninges were cut with a sterile needle to reveal the AP. A glass micropipette tip (outer diameter 50-75 µm) filled with DSAP or vehicle and affixed to a 1.0 microliter Hamilton syringe was positioned on the midline at the caudal limit of the AP, then moved 0.25 mm lateral and 0.5 mm below the medullary surface for the first injection site. A second more rostral injection site was located 0.25 mm below the lateral border of the AP at its widest rostrocaudal extent (35) . The two NST injection sites were then duplicated contralaterally. At each injection site, 50 nl of sterile 0.15M NaCl vehicle containing 0 or 5 ng DSAP was delivered by manual pressure injection over approximately 30 sec. The pipette tip was left in place for 2 min after each microinjection, then withdrawn. The skin incision was closed with sutures after the final injection. Rats were returned to their home cages after recovery from anesthesia. In addition to their regular chow diet, a palatable liquid diet (Vanilla flavored Ensure; Abbot Laboratories; 25 mls/day) was offered for 2 days before and for 5-7 days after DSAP or sham injection surgery. All rats consumed both liquid and solid diets, and DSAP and sham control rats gained equivalent amounts of body weight during the post-surgical period. Plain water was returned 30 min later, and rats had ad libitum water access for 24-48 hr.
For the final two-bottle choice test, rats were water deprived for 22 hr, and then given 30 Flavor preference ratios displayed by each rat during the two-bottle choice test were averaged within each treatment group to obtain group preference ratios (mean ± SE) for intake of saline-paired flavors relative to LiCl-paired flavors. Outcomes indicating significantly shifted preference ratios (e.g., 75%:25%) were interpreted as evidence for conditioned avoidance of the flavor represented by the lower value in the ratio. Paired t-tests were used to determine whether differences in preference for saline-paired vs. LiCl-paired flavors were statistically different, with significance set at P < 0.05.
Food intake experiment. One week after completing the CFA experiment, DSAP and sham control rats were tested for the ability of LiCl treatment to inhibit food intake. For this purpose, rats were moved from their original colony room to a new environment with the same 12:12 hr light-dark cycle. Rats were housed individually in clear plexiglass boxes (25 cm x 30 cm floor, 22 cm height) with stainless steel rod floors, each equipped with a computer-driven pellet delivery and monitoring system (Med Associates). Drinking water was available ad libitum from sipper tubes within each box. Food access was restricted to a daily 3 hr period beginning at lights out (1900 h), when a single 45 mg chow pellet (Precision Dustless Pellets;
Bio-Serv, Inc.; Frenchtown, NJ) was delivered automatically to a shallow feeding trough in each cage, thereby breaking a laser photobeam crossing the base of the trough. A new pellet was delivered automatically each time the preceding pellet was removed. The cumulative number of pellet deliveries (i.e., photobeam breaks) was recorded automatically at 30 min intervals during the 3 h feeding period. Cage trays beneath the open rod floors were routinely inspected at the end of the feeding period to confirm that delivered pellets were actually consumed. Data were collected and stored using Med PC software (Med Associates). Rats were acclimated to the new environment and feeding schedule for one week prior to testing, by which time stable daily 3 h food intakes of approximately 20-22 g per rat (i.e., ~7.5-8.5% BW) were achieved.
On testing day 1, rats were injected i.p. with 0.15M NaCl (2% BW) at 1830 hr. Food access was initiated 30 min later, at lights out (1900 hr). Cumulative pellet delivery data were collected for 3 h. On testing day 2 (24 hrs later), rats were injected i.p. with 0.15M LiCl (2% BW) at 1850 hr. Food access was initiated 30 min later, at lights out (1900 hr). Cumulative pellet delivery data were collected for 3 hr. Thus, each DSAP or sham control rat served as its own control for the effects of i.p. saline vs. i.p. LiCl on subsequent food intake. Rats were returned to their original home cages with ad libitum chow access after testing day 2.
Food intake data (i.e., the number of 45 mg pellets consumed over 3 hr) were combined a priori according to NST injection group (DSAP vs. sham control) and expressed as group means ± SE at each 30 min time point. Group-and treatment-related differences in food intake were tested for statistical significance by using ANOVA, with NST injection (DSAP vs. sham), i.p. treatment (NaCl or LiCl), and time (30 min intervals) as independent variables. food intake, ANOVAs were followed up with post hoc t-tests using Dunn's (Bonferonni) correction for multiple comparisons. Differences were considered significant when P < 0.05. Peninsula Laboratories). CGRP provides a distinct neurochemical marker for the viscerosensory laPBN-to-CeA projection pathway (22, 59) , and in our previous study the CGRP-positive pathway was activated normally in DSAP-lesioned rats after CCK treatment (35) . CRH immunostaining identifies parvocellular PVN neurons that comprise the apex of the HPA stress axis, and in our previous study CCK-induced activation of CRH neurons was markedly attenuated in DSAP-lesioned rats after CCK treatment (35) . Immunoreacted sections were mounted out of buffer onto charged glass microscope slides (SuperFrost Plus;
Fisher Scientific), dehydrated in a graded ethanol series, defatted in xylene, and coverslipped with Histomount (VWR, Pittsburgh, PA). In each rat, regional cell count data were expressed as the number of cells counted within each specified brain region summed bilaterally, divided by the number of analyzed tissue sections through the specified region, to obtain "average per section" values. Group data were combined a priori by NST injection group (i.e., DSAP vs. sham control) and expressed as mean counts ± SE for each brain region. Between-group differences in cell count values within each region were tested for statistical significance by using separate ttests, with NST injection condition (i.e., DSAP or vehicle) as the independent variable.
Differences were considered significant when P < 0.05.
Results

DSAP toxin injections eliminated a significant proportion of DbH-positive NST neurons.
Quantitative analysis revealed an average loss of approximately 49% of the NST NA neuronal population in DSAP rats relative to sham controls (Table 1) The hypophagic effect of LiCl treatment in sham control rats was maintained throughout the 3 hr post-injection monitoring period, ranging from approximately 70% inhibition of feeding at the 30 min time point to approximately 45% inhibition at the final 3 hr time point (FIg. 2) . The rate of eating (as evidenced by the slope of the lines connecting time points; Fig. 2 ) was suppressed to the greatest extent during the first 30 minutes of feeding in both sham and DSAP rats after LiCl compared with feeding after saline injections. Between the 30 and 60 min time points, DSAP rats ate at a somewhat higher rate than sham rats, which produced the statistically significant difference in food intake evident at the 60 min and later time points (Fig.   2 ). The ability of LiCl to inhibit food intake in DSAP rats was significantly attenuated at most time points (Fig. 2, asterisks) , although DSAP rats as a group still exhibited LiCl-induced hypophagia across the 3 hr monitoring period [F(1,26) = 53.39, P < 0.05]. However, within the 3 hr monitoring period, neither group compensated for the reduced food intake that was most evident during the initial 30-60 min of the 3 hr monitoring period.
The suppressive effect of LiCl on cumulative food intake at the final 3 hr time point was more markedly attenuated in rats with more complete DSAP lesions ( Fig. 3 ; lesion data described further, below). A significant correlation existed between lesion extent and the magnitude of LiCl-induced hypophagia at this time point in DSAP rats (Pearson r = -0.531; P < 0.05), such that larger lesions were associated with less feeding suppression after LiCl compared to intake after saline injections. Conversely, grouping animals by DSAP lesion extent did not reveal any differences among groups in results from the 2-bottle choice test that demonstrated similarly robust CFA responses to LiCl (see Fig. 3 ).
DSAP-induced loss of DbH-immunopositive NA neurons
Bilateral toxin injections were associated with an average 49% reduction of DbH-positive NST neurons in DSAP rats compared with sham controls ( Table 1 , Fig. 4A,B) . The loss of DbHpositive NST neurons in DSAP rats was statistically significant (t-test, P < 0.01). Marked loss of DbH-positive neurons within the AP also was observed in DSAP rats (Fig. 4A,B (Table 1) , evidence for the relative confinement of the DSAP lesion within the dorsal medial medulla.
Compared with results from our previous study (35) in which 6 toxin injection sites were made in each animal, DSAP lesion extent in the present study was more variable (i.e., 3-84% loss of DbH-positive NST neurons) and we obtained a larger proportion of DSAP rats with NA lesions that were less than 50% complete. However, DSAP lesions in the present study were more anatomically restricted than in our previous report, with no significant loss of A1/C1 neurons in the caudal VLM (Table 1) .
LiCl-induced Fos expression in DSAP and sham control rats
Hindbrain: The average numbers of Fos-positive profiles counted per tissue section within the AP and NST were similar in DSAP and sham control rats after LiCl treatment ( Table   2 , Fig. 4C,D (Table 1) , the proportion of remaining DbH-positive NST neurons activated in DSAP rats after LiCl treatment (i.e. 70.5%) was statistically similar to the proportion activated in sham controls (i.e., 64.4%; Table 2 ). DbH-positive NA neurons within the caudal VLM also were similarly activated after LiCl treatment in DSAP and sham control rats (i.e., 34.8% and 38.0%, respectively; Table 2 ).
Hypothalamus: DSAP lesions were associated with reduced DbH immunolabeling throughout magnocellular and parvocellular subdivisions of the PVN (Fig. 5A,B ). DSAP lesions also were associated with reduced PVN Fos expression after LiCl treatment, including a significant attenuation of Fos expression by CRH-immunopositive neurons within the mpPVN ( Table 2 , Fig. 5C,D) . LiCl activated 44.1% fewer CRH-positive neurons in DSAP rats compared with CRH activation in sham controls ( Table 2 ; P < 0.05). Conversely, LiCl-induced Fos expression within the lateral magnocellular PVN appeared similarly robust in DSAP and sham control rats (Fig. 5C,D) . A significant correlation existed between NA lesion extent in (Fig. 6A,B) and CeA ( Fig. 6C,D) was not attenuated in DSAP rats. Quantitative analysis confirmed that similar numbers of CGRP-positive laPBN neurons and similar numbers of cells within the CGRP-rich region of the CeA were activated to express Fos in DSAP and sham control rats after LiCl treatment ( Table 2 , Fig. 6 ).
Discussion
Results from this study support the view that NA neurons in the caudal dorsomedial medulla contribute to LiCl-induced hypophagia, and also are important for conveying LiCl-related interoceptive signals to CRH-positive neurons in the mpPVN. Conversely, DSAP lesions of this NA cell population did not affect LiCl-induced activation of neurons within the laPBN or CeA, and did not reduce the ability of LiCl to support CFA. These results are striking, as they illustrate a unique experimental situation in which this "nauseogenic", malaise-inducing agent maintains its ability to support robust conditioned avoidance in animals in which hypophagic responses to the same agent are significantly attenuated.
An earlier study reported that aspiration lesions of the AP block the ability of LiCl to support CFA without significantly affecting LiCl-induced hypophagia (6) . That result is perhaps easier to reconcile with the knowledge that many natural conditions and experimental treatments inhibit food intake without also producing conditioned avoidance behavior, presumably because those situations and treatments are not aversive. On the other hand, conditioned avoidance also can occur in the absence of demonstrable hyophagia. Certain doses of LiCl that are sub-threshold for inhibiting food intake in rats have been reported to support comparatively mild but still significant and dose-related conditioned avoidance (2, 9) .
Conversely, we are unaware of another experimental condition in which a robust CFA induced by a relatively high dose of LiCl is maintained without a similarly robust unconditioned hypophagic response, as occurred in rats with the most complete DSAP lesions.
DSAP lesion efficacy and specificity
Bilateral NST microinjections of DSAP were designed to destroy NA neurons in the caudal medial NST, corresponding to the location of the A2 cell group and the caudal portion of the C2 cell group. Results from previous studies attest to the efficacy and specificity of the conjugated DSAP toxin (1, 11, 12, 25, 35, 39, 56) . In the present study, toxin-induced loss of 
NA cell loss, hypophagia, and CFA
As in our previous DSAP study examining the effect of NA lesions on CCK-induced hypophagia (35), a positive correlation was found in the present study between the number of surviving DbH-positive NA neurons in the caudal NST and the extent of LiCl-induced hypophagia. As shown in Figure 3 , the more effective the DSAP lesion, the more blunted the ability of LiCl to inhibit food intake. Rats with the most complete DSAP lesions (i.e., approximately 80% loss of NA neurons) displayed significantly less LiCl-induced hypophagia than sham control rats or DSAP rats with less complete lesions. Thus, not only are NA neurons in the caudal dorsomedial medulla activated by LiCl and CCK, they underlie at least a significant portion of the ability of these agents to inhibit food intake. It should be noted that DSAP lesions in the present study were never 100% complete; thus, it remains unclear whether NA neurons are absolutely necessary for treatment-induced hypophagia. We cannot rule out the possibility that more extensive NA lesions would disrupt LiCl-induced CFA and/or Fos responses in the laPBN and CeA. Considered together, however, these findings support the view that NA neurons in the NST contribute importantly to brainstem circuits that suppress food intake. These circuits likely include known NA inputs to regions of the medullary and pontine reticular formation (7) that contain the pre-motor and motor neurons that ultimately control ingestive behavior (49) .
DSAP lesions reduce PVN activation after LiCl
In addition to inhibiting food intake in rats, systemic LiCl activates the HPA stress axis and also increases plasma levels of oxytocin, and, to a lesser degree, vasopressin (6, 10, 50, 51, 54) . Plasma hormone levels were not assayed in the present study, but the significantly blunted Fos expression by CRH-positive mpPVN neurons in DSAP rats predicts a similarly blunted HPA response to LiCl treatment. Indeed, a close association between treatmentinduced Fos activation in CRH neurons and plasma corticosterone levels has been reported (1) . Our finding of reduced Fos expression in mpPVN CRH-positive neurons in DSAP rats after LiCl treatment is consistent with a previous report of reduced mpPVN activation in DSAP rats after CCK treatment (35) . Conversely, despite significant loss of DbH-immunoreactive fibers throughout the PVN in DSAP rats, LiCl-induced Fos activation in the lateral magnocellular PVN appeared to be intact, presumably due to remaining inputs from neurons other than dorsomedial medullary NA neurons. Likely candidates include NA neurons in the caudal VLM, which were not lesioned in DSAP rats, and which project directly to the vasopressin-rich core of the lateral magnocellular PVN (4, 5, 44, 52) .
DSAP lesions do not attenuate laPBN or CeA activation after LiCl
In contrast to the decremented mpPVN activation in DSAP rats after LiCl, activation of the CRGP-containing pathway from laPBN to CeA (59) was quantitatively unaffected. We interpret this dissociation as evidence that NA neurons in the caudal dorsomedial medulla are unnecessary for conveying LiCl-related viscerosensory signals to the CeA, probably because these signals are relayed through CGRP neurons in the laPBN that innervate the CeA. Direct NST projections to the amygdala include a prominent NA component that is activated by LiCl and other experimental treatments that inhibit food intake and promote conditioned avoidance behavior (28) (29) (30) . However, the laPBN is a major relay for ascending viscerosensory inputs from the caudal medulla to the amygdala (15, 18, 33, 43, 53) . NST and AP inputs to the laPBN are predominantly excitatory, and arise from both NA and non-NA neurons (15, 16, 19) .
Subpopulations of neurons within the NST and laPBN project differentially to brainstem and forebrain target regions, suggesting that different types of viscerosensory signals may be carried through different projection pathways. For example, systemic administration of endotoxin in rats activates ten times as many CeA-projecting neurons in the laPBN than CeAprojecting neurons in the NST (53) . Neurons within the laPBN, including CGRP-positive neurons, project rather weakly to the PVN and lateral hypothalamus but strongly to the CeA and bed nucleus of the stria terminalis (BNST) in rats and in humans (21, 22, 45, 59) . As another example, NA inputs to the mpPVN arise from caudal medullary NST and VLM neurons that also provide collateralized axonal inputs to the BNST, whereas NA inputs to the lateral magnocellular PVN arise from a separate population of hindbrain NA neurons (1) .
Although DbH-positive AP and NST neurons that project to the laPBN and amygdala undoubtedly were lesioned (to varying degrees) in DSAP rats, non-NA neurons that project to these regions presumably were spared. The latter include projections arising from serotoninergic AP neurons that target the laPBN (23) and from glucagon-like peptide-1 (GLP-1)-positive NST neurons that target the laPBN and CeA (24, 27) and are activated in intact rats after LiCl treatment (36) . We did not examine LiCl-induced activation of these neurons in the present study. However, in our previous DSAP study, GLP-1 neurons remained intact and were activated to express Fos after CCK treatment in rats with more extensive dorsal medullary NA lesions (35) . Thus, GLP-1 signaling pathways may contribute to the observed maintenance of LiCl-induced CFA in DSAP rats. Indeed, infusion of GLP-1 into the amygdala supports conditioned avoidance behavior in rats, and blockade of amygdalar GLP-1 receptors attenuates the ability of systemic LiCl to produce conditioned avoidance (20) . Conversely, infusion of GLP-1 directly into the amygdala does not inhibit food intake (20) . If GLP-1 pathways are sufficient to maintain CFA in rats with DSAP lesions, it is still unclear why they are not sufficient to maintain LiCl-induced hypophagia. Two laboratories have reported that global blockade of central GLP-1 receptors attenuates LiCl-induced hypophagia (34, 46) , but in neither study was the hypophagia eliminated. It should be noted that the hypophagic effect of systemic endotoxin is significantly attenuated by pharmacological antagonism of hindbrain but not forebrain GLP-1 receptors (14), that hindbrain NA neurons express GLP-1 receptors, and that central infusion of GLP-1 activates these neurons (57) . Thus, central GLP-1 signaling pathways may participate in hypophagic responses to LiCl because they recruit hindbrain NA neurons. It would be interesting to determine whether the ability of central GLP-1 to inhibit food intake is attenuated in rats with DSAP lesions of these neurons.
We conclude that NA neurons within the dorsomedial medulla (AP and/or NST) contribute importantly to LiCl-induced hypophagia and also to recruitment of stress-responsive mpPVN neurons, but are unnecessary for the ability of LiCl to support robust CFA learning and expression. Our findings support the view that the behavioral effects of LiCl are mediated by CNS circuits that are at least partially dissociable.
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